DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
Our Founder
HONORING THE LEGACY OF LAURIE HALLORAN
Laurie Halloran was a revered and beloved mentor and friend to hundreds of leaders across the life science industry. As founder of Halloran Consulting Group, Laurie spent her entire career dedicated to sharing best practices and know-how in life science to deliver safe and effective products to patients. She started her career as a pediatric ICU nurse and, in 1998, was inspired to start a company that helps move new therapies through FDA processes to get them into the hands of patients desperately in need. Since its humble beginnings, Halloran has grown into a thriving consultancy of like-minded experts dedicated to improving human health.
In conjunction with the 25th anniversary of Halloran Consulting Group, Laurie officially stepped into her role as Founder to focus on her life’s passions: family, mentoring, and travel. For more than a decade, she mentored and guided a select group of leaders and handed the reigns over to this team so they could advance the company to the next phase of strategic corporate maturity to serve the life science community.
“We are heartbroken with the news of Laurie’s passing. We know that the best way to move forward as a company and community is to be the torch bearers of her dream,” stated Tania Zieja, President, Halloran Consulting Group. “Our leadership team is invested in growing her legacy in honor of her vision and example.”
In February 2023, Laurie joined 20 of her biotech leaders to summit Mount Kilimanjaro, raising $1 million to fuel scientific discovery for the Fred Hutchinson Cancer Center.
Laurie was recognized numerous times over the years. In November 2023, she was honored as the Boston Business Journal’s Power 50: Movement Makers and as The Women’s Edge, together with its partner The Boston Globe, Top 100 Women-Led Businesses in Massachusetts. In 2018, she was the WBENC Star and won a 2017 Enterprising Women of the Year Award from Enterprising Women Magazine. In 2015, Laurie was honored by the Boston Business Journal as a Woman of Influence, and the company received a ranking in the INC 500 fastest-growing companies. In 2010, Laurie was selected as one of the 100 Most Inspiring People in Life Science by PharmaVoice.
Prior to her passing, Laurie lectured at BU Medical School and the Tufts Center for Drug Development Post-Graduate program. She was a founding member of MedExec Women, served as an Advisor to the Convergence Forum, and was a Co-Founder and board member of CRUSH Life Sciences.
Additionally, she previously served on Advisory Board positions at Boston University’s School of Public Health, Lesley University Alumni Advisory Board, Merck/EMD Serono’s Precision Medicine, and the New England Women in Science Executive’s Board of Directors. Laurie held many memberships in professional associations, including the Oncology Nursing Society, Drug Information Association, and the Associates of Clinical Research Professionals.
Laurie earned a Bachelor of Science in Nursing from Russell Sage College and a Master of Science in Management from Lesley University. She was also a Prosci Certified Change Practitioner.
Prior to starting Halloran, Laurie held positions at St. Mary’s Hospital, Albany (NY) Medical Center Hospital, Children’s Hospital (Boston, MA), Trustees of Health and Hospitals (Boston, MA), Medical & Technical Research Associates, Parexel International Corporation, OXiGENE, Inc., and Antigenics, Inc.
In June 2024, Determined to be Extraordinary, a book by Dawn Heimer, Ph.D, was published and dedicated in Laurie Halloran's honor. Before her passing, Laurie was asked by Dawn to contribute to the book which focuses on the incredible stories of women leaders in STEM.
CHARITABLE GIVING
Memorial donations can be made to the Sean M. Healey & AMG Center for ALS or to Life Science Cares in Laurie’s memory.